SMMT: Summit Therapeutics Inc
今日SMMT汇率已更改-1.77%。当日,交易品种以低点15.13和高点15.70进行交易。
关注Summit Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SMMT新闻
- Summit Expands Ivonescimab Development Into Biliary Tract Cancer
- Can Expanding Ivonescimab Development Unlock SMMT's Growth Potential?
- Summit Therapeutics Announces Clinical Trial Collaboration With The ECOG-ACRIN Cancer Research Group To Evaluate Ivonescimab In A Phase II/III Study In Biliary Tract Cancer
- Summit Therapeutics Announced Opening Of Global Phase II SMT112-216 Trial Of Ivonescimab Alone Or Combined With Cadonilimab Or Ipilimumab In Previously Untreated Advanced Clear Cell Renal Cell Carcinoma,
- 芯片股下跌,韩国KOSPI暴跌,强生下跌6%:今日股市行情
- Chip Stocks Slide as South Korea's KOSPI Plunges, J&J Sinks 6%: Stock Market Today
- 10 Health Care Stocks With Whale Alerts In Today’s Session
- Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
- 亚马逊、Alphabet、特斯拉股价上涨:Robinhood交易者仍然卖出
- Amazon, Alphabet, Tesla Stock Rises: Robinhood Traders Sell Anyway
- SMMT Inks Deal With AZN-Daiichi to Study Ivonescimab + Datroway Combos
- Summit Therapeutics Announces Closing Of AstraZeneca's $2B Convertible Preferred Investment, Equivalent To $18.36/Share Of Common Stock
- BioNTech SE: Moving Past Covid (NASDAQ:BNTX)
- AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership
- Summit Therapeutics, AstraZeneca And Daiichi Sankyo Announce Clinical Trial Collaboration To Evaluate Ivonescimab With TROP2-Directed ADC Datroway Across Multiple Tumor Types, Starting With Phase III First-Line Triple-Negative Breast Cancer Study
- Robinhood Traders Just Went on Their Biggest Buying Binge Ever
- Robinhood交易者刚刚经历了史上最大规模的买入狂潮
- Barclays Maintains Equal-Weight on Summit Therapeutics, Raises Price Target to $20
- Summit Therapeutics 股票周三上涨:发生了什么?
- Summit Therapeutics Stock Climbs Wednesday: What's Happening?
- Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today
- 纳斯达克100指数上涨,因较低的PCE数据削弱加息预期,Micron财报将至:今日股市
- Stocks Settle Mixed as Bond Yields Rise
- A $2 Billion Reason Why AstraZeneca Stock Is Down Today
常见问题解答
SMMT股票今天的价格是多少?
Summit Therapeutics Inc股票今天的定价为15.55。它在15.13 - 15.70范围内交易,昨天的收盘价为15.83,交易量达到7995。SMMT的实时价格图表显示了这些更新。
Summit Therapeutics Inc股票是否支付股息?
Summit Therapeutics Inc目前的价值为15.55。股息政策取决于公司,而投资者也会关注-17.53%和USD。实时查看图表以跟踪SMMT走势。
如何购买SMMT股票?
您可以以15.55的当前价格购买Summit Therapeutics Inc股票。订单通常设置在15.55或15.85附近,而7995和1.70%显示市场活动。立即关注SMMT的实时图表更新。
如何投资SMMT股票?
投资Summit Therapeutics Inc需要考虑年度范围12.07 - 29.23和当前价格15.55。许多人在以15.55或15.85下订单之前,会比较-7.55%和。实时查看SMMT价格图表,了解每日变化。
Summit Therapeutics Inc股票的最高价格是多少?
在过去一年中,Summit Therapeutics Inc的最高价格是29.23。在12.07 - 29.23内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Summit Therapeutics Inc的绩效。
Summit Therapeutics Inc股票的最低价格是多少?
Summit Therapeutics Inc(SMMT)的最低价格为12.07。将其与当前的15.55和12.07 - 29.23进行比较,可以发现潜在的长期切入点。观看SMMT在图表上的实时走势以获取更多详细信息。
SMMT股票是什么时候拆分的?
Summit Therapeutics Inc历史上曾经历过股票拆分。这些变化在公司行动后的、15.83和-17.53%中可见。
- 前一天收盘价
- 15.83
- 开盘价
- 15.29
- 卖价
- 15.55
- 买价
- 15.85
- 最低价
- 15.13
- 最高价
- 15.70
- 交易量
- 7.995 K
- 日变化
- -1.77%
- 月变化
- -7.55%
- 6个月变化
- -2.93%
- 年变化
- -17.53%
- 实际值
- 48.0
- 预测值
- 46.3
- 前值
- 46.3
- 实际值
- 48.8
- 预测值
- 47.3
- 前值
- 47.3
- 实际值
- 4.7%
- 预测值
- 4.7%
- 前值
- 4.7%
- 实际值
- 3.5%
- 预测值
- 3.5%
- 前值
- 3.5%
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 207.9 K
- 实际值
- 预测值
- 前值
- 100.3 K
- 实际值
- 预测值
- 前值
- -141.0 K
- 实际值
- 预测值
- 前值
- 48.5 K